Logo image of CSAN

COSAN SA -ADR (CSAN) Stock Fundamental Analysis

NYSE:CSAN - New York Stock Exchange, Inc. - US22113B1035 - ADR - Currency: USD

5.44  +0.09 (+1.68%)

After market: 5.44 0 (0%)

Fundamental Rating

4

CSAN gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 213 industry peers in the Oil, Gas & Consumable Fuels industry. Both the profitability and financial health of CSAN have multiple concerns. CSAN is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

CSAN had negative earnings in the past year.
In the past year CSAN had a positive cash flow from operations.
CSAN had positive earnings in 4 of the past 5 years.
Each year in the past 5 years CSAN had a positive operating cash flow.
CSAN Yearly Net Income VS EBIT VS OCF VS FCFCSAN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B 10B

1.2 Ratios

CSAN's Return On Assets of -6.67% is on the low side compared to the rest of the industry. CSAN is outperformed by 79.34% of its industry peers.
CSAN has a worse Return On Equity (-86.43%) than 88.26% of its industry peers.
Looking at the Return On Invested Capital, with a value of 4.11%, CSAN is doing worse than 62.91% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CSAN is significantly below the industry average of 25.88%.
Industry RankSector Rank
ROA -6.67%
ROE -86.43%
ROIC 4.11%
ROA(3y)-1.67%
ROA(5y)0.73%
ROE(3y)-25.17%
ROE(5y)-5.22%
ROIC(3y)4.36%
ROIC(5y)4.21%
CSAN Yearly ROA, ROE, ROICCSAN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60 -80

1.3 Margins

Looking at the Operating Margin, with a value of 14.59%, CSAN is in line with its industry, outperforming 46.01% of the companies in the same industry.
In the last couple of years the Operating Margin of CSAN has declined.
CSAN's Gross Margin of 31.20% is in line compared to the rest of the industry. CSAN outperforms 42.25% of its industry peers.
In the last couple of years the Gross Margin of CSAN has remained more or less at the same level.
Industry RankSector Rank
OM 14.59%
PM (TTM) N/A
GM 31.2%
OM growth 3Y3.25%
OM growth 5Y-3.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.35%
GM growth 5Y1.27%
CSAN Yearly Profit, Operating, Gross MarginsCSAN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CSAN is destroying value.
CSAN has less shares outstanding than it did 1 year ago.
The number of shares outstanding for CSAN has been increased compared to 5 years ago.
The debt/assets ratio for CSAN is higher compared to a year ago.
CSAN Yearly Shares OutstandingCSAN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
CSAN Yearly Total Debt VS Total AssetsCSAN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B

2.2 Solvency

CSAN has an Altman-Z score of 0.65. This is a bad value and indicates that CSAN is not financially healthy and even has some risk of bankruptcy.
CSAN's Altman-Z score of 0.65 is on the low side compared to the rest of the industry. CSAN is outperformed by 61.50% of its industry peers.
The Debt to FCF ratio of CSAN is 13.94, which is on the high side as it means it would take CSAN, 13.94 years of fcf income to pay off all of its debts.
CSAN has a Debt to FCF ratio (13.94) which is comparable to the rest of the industry.
A Debt/Equity ratio of 6.20 is on the high side and indicates that CSAN has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 6.20, CSAN is doing worse than 90.61% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 6.2
Debt/FCF 13.94
Altman-Z 0.65
ROIC/WACC0.43
WACC9.62%
CSAN Yearly LT Debt VS Equity VS FCFCSAN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.3 Liquidity

CSAN has a Current Ratio of 1.72. This is a normal value and indicates that CSAN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.72, CSAN is in the better half of the industry, outperforming 71.36% of the companies in the same industry.
A Quick Ratio of 1.60 indicates that CSAN should not have too much problems paying its short term obligations.
CSAN has a better Quick ratio (1.60) than 72.77% of its industry peers.
Industry RankSector Rank
Current Ratio 1.72
Quick Ratio 1.6
CSAN Yearly Current Assets VS Current LiabilitesCSAN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

7

3. Growth

3.1 Past

The earnings per share for CSAN have decreased strongly by -998.95% in the last year.
The Revenue has grown by 11.36% in the past year. This is quite good.
CSAN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 26.51% yearly.
EPS 1Y (TTM)-998.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-687.06%
Revenue 1Y (TTM)11.36%
Revenue growth 3Y20.84%
Revenue growth 5Y26.51%
Sales Q2Q%-69.69%

3.2 Future

Based on estimates for the next years, CSAN will show a very strong growth in Earnings Per Share. The EPS will grow by 36.92% on average per year.
The Revenue is expected to grow by 62.96% on average over the next years. This is a very strong growth
EPS Next Y134.43%
EPS Next 2Y52.78%
EPS Next 3Y36.92%
EPS Next 5YN/A
Revenue Next Year3.65%
Revenue Next 2Y3.57%
Revenue Next 3Y62.96%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CSAN Yearly Revenue VS EstimatesCSAN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200B 400B 600B
CSAN Yearly EPS VS EstimatesCSAN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 10 -10 -20

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CSAN. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 4.34 indicates a rather cheap valuation of CSAN.
CSAN's Price/Forward Earnings ratio is rather cheap when compared to the industry. CSAN is cheaper than 94.37% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.94, CSAN is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 4.34
CSAN Price Earnings VS Forward Price EarningsCSAN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CSAN is valued a bit cheaper than the industry average as 64.32% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, CSAN is valued cheaply inside the industry as 94.84% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 2.73
EV/EBITDA 6.18
CSAN Per share dataCSAN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CSAN's earnings are expected to grow with 36.92% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y52.78%
EPS Next 3Y36.92%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.96%, CSAN is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 7.03, CSAN pays a bit more dividend than its industry peers.
CSAN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.36.
Industry RankSector Rank
Dividend Yield 5.96%

5.2 History

On average, the dividend of CSAN grows each year by 25.09%, which is quite nice.
CSAN has been paying a dividend for over 5 years, so it has already some track record.
CSAN has decreased its dividend recently.
Dividend Growth(5Y)25.09%
Div Incr Years1
Div Non Decr Years1
CSAN Yearly Dividends per shareCSAN Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 0.5 1

5.3 Sustainability

The earnings of CSAN are negative and hence is the payout ratio. CSAN will probably not be able to sustain this dividend level.
CSAN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-36.58%
EPS Next 2Y52.78%
EPS Next 3Y36.92%
CSAN Yearly Income VS Free CF VS DividendCSAN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B

COSAN SA -ADR

NYSE:CSAN (5/21/2025, 7:00:00 PM)

After market: 5.44 0 (0%)

5.44

+0.09 (+1.68%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-14 2025-05-14
Earnings (Next)08-13 2025-08-13
Inst Owners31.72%
Inst Owner Change-12.55%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.53B
Analysts80
Price Target7 (28.68%)
Short Float %0.67%
Short Ratio1.61
Dividend
Industry RankSector Rank
Dividend Yield 5.96%
Yearly Dividend1.31
Dividend Growth(5Y)25.09%
DP-36.58%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-949.62%
Min EPS beat(2)-1830.24%
Max EPS beat(2)-69.01%
EPS beat(4)0
Avg EPS beat(4)-536.79%
Min EPS beat(4)-1830.24%
Max EPS beat(4)-29.45%
EPS beat(8)1
Avg EPS beat(8)-274.48%
EPS beat(12)2
Avg EPS beat(12)-181.05%
EPS beat(16)5
Avg EPS beat(16)-121.79%
Revenue beat(2)0
Avg Revenue beat(2)-73.28%
Min Revenue beat(2)-74.31%
Max Revenue beat(2)-72.24%
Revenue beat(4)0
Avg Revenue beat(4)-72.93%
Min Revenue beat(4)-74.31%
Max Revenue beat(4)-72.08%
Revenue beat(8)0
Avg Revenue beat(8)-40.01%
Revenue beat(12)0
Avg Revenue beat(12)-51.56%
Revenue beat(16)0
Avg Revenue beat(16)-57.74%
PT rev (1m)-4.1%
PT rev (3m)-6.6%
EPS NQ rev (1m)183.75%
EPS NQ rev (3m)-83.53%
EPS NY rev (1m)0%
EPS NY rev (3m)-13.18%
Revenue NQ rev (1m)-4.14%
Revenue NQ rev (3m)2.58%
Revenue NY rev (1m)1.27%
Revenue NY rev (3m)2.64%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 4.34
P/S 0.32
P/FCF 2.73
P/OCF 1.09
P/B 1.31
P/tB N/A
EV/EBITDA 6.18
EPS(TTM)-3.64
EYN/A
EPS(NY)1.25
Fwd EY23.03%
FCF(TTM)2
FCFY36.69%
OCF(TTM)4.99
OCFY91.69%
SpS16.76
BVpS4.16
TBVpS-5.88
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.67%
ROE -86.43%
ROCE 5.2%
ROIC 4.11%
ROICexc 4.91%
ROICexgc 6.59%
OM 14.59%
PM (TTM) N/A
GM 31.2%
FCFM 11.91%
ROA(3y)-1.67%
ROA(5y)0.73%
ROE(3y)-25.17%
ROE(5y)-5.22%
ROIC(3y)4.36%
ROIC(5y)4.21%
ROICexc(3y)5.12%
ROICexc(5y)5.21%
ROICexgc(3y)6.64%
ROICexgc(5y)7.56%
ROCE(3y)5.52%
ROCE(5y)5.33%
ROICexcg growth 3Y5.58%
ROICexcg growth 5Y-20.62%
ROICexc growth 3Y6.6%
ROICexc growth 5Y-13.61%
OM growth 3Y3.25%
OM growth 5Y-3.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.35%
GM growth 5Y1.27%
F-Score5
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 6.2
Debt/FCF 13.94
Debt/EBITDA 6.57
Cap/Depr 202.84%
Cap/Sales 17.85%
Interest Coverage 1.25
Cash Conversion 127.24%
Profit Quality N/A
Current Ratio 1.72
Quick Ratio 1.6
Altman-Z 0.65
F-Score5
WACC9.62%
ROIC/WACC0.43
Cap/Depr(3y)179.81%
Cap/Depr(5y)178.28%
Cap/Sales(3y)15.09%
Cap/Sales(5y)13.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-998.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-687.06%
EPS Next Y134.43%
EPS Next 2Y52.78%
EPS Next 3Y36.92%
EPS Next 5YN/A
Revenue 1Y (TTM)11.36%
Revenue growth 3Y20.84%
Revenue growth 5Y26.51%
Sales Q2Q%-69.69%
Revenue Next Year3.65%
Revenue Next 2Y3.57%
Revenue Next 3Y62.96%
Revenue Next 5YN/A
EBIT growth 1Y-14.98%
EBIT growth 3Y24.77%
EBIT growth 5Y21.84%
EBIT Next Year119.14%
EBIT Next 3Y37.51%
EBIT Next 5YN/A
FCF growth 1Y30.58%
FCF growth 3Y65.47%
FCF growth 5Y21.36%
OCF growth 1Y27.29%
OCF growth 3Y35.81%
OCF growth 5Y36.03%